The Use of Self Inflating Tissue Expanders In The Treatment Of Alveolar Cleft

NCT ID: NCT03010345

Last Updated: 2017-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

patient receiving treatment using the osmed expander will have enough soft tissue coverage securing the bone graft which will be placed in a later stage to close the alveolar cleft.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

to prove that the group treated with osmed expanders will suffer no soft tissue dehiscence and will have a higher volume of soft tissue at the stage of bone grafting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cleft of Alveolar Ridge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Osmed self inflating tissue expanders

All patients will undergo a two-stage procedure ,second stage under General endotracheal anesthesia. The first stage will be placement of the expanders. The second stage will be 21 days later, with removal of the expanders, palatal revision, and closure of the oronasal fistula

Group Type EXPERIMENTAL

Osmed self inflating tissue expanders

Intervention Type DEVICE

Osmed self inflating tissue expanders will be placed 21 days before bone grafting the cleft to gain soft tissue coverage

Iliac bone graft

Placement of bone graft without the use of self inflating expanders

Group Type EXPERIMENTAL

Iliac bone graft

Intervention Type OTHER

Bone grafting the cleft without the use of osmed self inflating tissue expander

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Osmed self inflating tissue expanders

Osmed self inflating tissue expanders will be placed 21 days before bone grafting the cleft to gain soft tissue coverage

Intervention Type DEVICE

Iliac bone graft

Bone grafting the cleft without the use of osmed self inflating tissue expander

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medically free patients.
* Patients suffering from alveolar cleft with anterior fistulas.
* Age Between 7 and 13 Years
* Both sexes.
* Patients physically able to tolerate surgical and restorative procedures. Good oral hygiene.
* Highly motivated patients.

Exclusion Criteria

* non motivated patients
Minimum Eligible Age

7 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sherif Hany shams

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Galal El Behiry, Phd

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo university

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cairo university kasr el ainy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.